Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. However, such procedures ...

Researchers at Hannover Medical School have developed a benchtop bioreactor system that can generate up to 40 million human macrophages per week from induced pluripotent stem cells. The medium-scale ...

Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...

Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that ...

Southwest Research Institute demonstrated its single-use 3D bioreactor to produce induced Pluripotent Stem Cells (iPSCs), derived from adult skin, blood, and other somatic cells. Useful for ...

A team of scientists at the Institute for Cell Biology (Cancer Research), University of Duisburg-Essen, has developed a simple method for the automated manufacture of induced pluripotent stem cell ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

GBI Biomanufacturing's Plantation plant has wrapped a multimillion dollar expansion that company officials say doubles its ...

One of the most important advances in the field of cell biology came in the early 20th century, with the discovery that plant and animal cells could survive - and even replicate - outside the living ...